1. Chloroquinoxaline sulfonamide: A sulfanilamide antitumor agent entering clinical trials

   • Jason S. Fisherman
   • Blaire L. Osborn
   • Robert H. Shoemaker

   OriginalPaper Pages: 1 - 9

2. Cytotoxicity of crotoxin on murine erythroleukemia cellsin vitro

   • Robert E. Corin
   • Luis J. Viskatis
   • Martin A. Etcheverry

   OriginalPaper Pages: 11 - 15

3. A phase I clinical and pharmacokinetic study of the oral and the oral/ intravenous administration of menogaril

   • Geoffrey R. Weiss
   • Thomas D. Brown
   • Dorothy A. Kasunic

   OriginalPaper Pages: 17 - 27

4. Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer

   • Bruce E. Johnson
   • Robert Parker
   • Daniel C. Ihde

   OriginalPaper Pages: 29 - 37

5. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma

   • Kapil Dhingra
   • Nicholas Papadopoulos
   • Sewa S. Legha

   OriginalPaper Pages: 39 - 43

6. Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma

   • Walter H. Harvey
   • Thomas R. Fleming
   • John S. MacDonald

   OriginalPaper Pages: 45 - 46

7. Amonafide treatment of refractory esophageal cancer

   • Elizabeth Poplin
   • Tom Fleming
   • Marcel E. Conrad

   OriginalPaper Pages: 47 - 51

8. A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer

   • David G. Pfister
   • Dean Bajorin
   • George Bosl

   OriginalPaper Pages: 53 - 56

9. Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer

   • Narin Voravud
   • Scott M. Lippman
   • Waun Ki Hong

   OriginalPaper Pages: 57 - 60

10. Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer

    • Malcolm Moore
    • Jean Maroun
    • John Gyves

    OriginalPaper Pages: 61 - 65

11. Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma

    • Jaffer A. Ajani
    • James L. Abbruzzese
    • Karen Daugherty

    OriginalPaper Pages: 67 - 69

12. Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer

    • Noa Ben-Baruch
    • Andrea M. Denicoff
    • Kenneth H. Cowan

    OriginalPaper Pages: 71 - 74

13. Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer

    • G. T. Budd
    • R. M. Bukowski
    • R. Ganapathi

    OriginalPaper Pages: 75 - 79

14. Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer

    • Stephen K. Williamson
    • John Crowley
    • Geoffrey Weiss

    OriginalPaper Pages: 81 - 83

15. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer

    • Jose Baselga
    • Mark G. Kris
    • Robert T. Heelan

    OriginalPaper Pages: 85 - 86

16. Phase II study of sulofenur (LY 186641)

    • Nikhil C. Munshi
    • David E. Seitz
    • Lawrence H. Einhorn

    OriginalPaper Pages: 87 - 90

17. Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study

    • Robert Chapman
    • John Crowley
    • Harry E. Hynes

    OriginalPaper Pages: 91 - 92

18. New formulation intravenous melphalan in the treatment of patients with metastitic renal cancer

    • Carla I. Falkson

    OriginalPaper Pages: 93 - 93

19. Book review

    • J. Tami
    • A. R. Hanauske

    BookReview Pages: 95 - 97

20. Third anticancer drug discovery and development symposium

    Report Pages: 99 - 100